IPO
Search documents
IPO周报 | 三生制药分拆蔓迪国际赴港上市;海伟电子港交所上市在即
IPO早知道· 2025-11-23 12:43
Group 1: Mandu International - Mandu International submitted its prospectus to the Hong Kong Stock Exchange on November 20, aiming for a main board listing, with Huatai International as the sole sponsor [3] - The company launched China's first 5% minoxidil solution in 2001, addressing the consumer medical demand for hair loss treatment, and has since developed various formulations to cater to different genders and scenarios [3] - Mandu's flagship product, the Mandu® series of minoxidil hair loss treatment products, has ranked first in the Chinese hair loss drug market for ten consecutive years, holding approximately 57% and 71% market shares in the hair loss drug and minoxidil drug markets respectively in 2024 [4] - Revenue figures for Mandu International from 2022 to 2024 are projected at 982 million yuan, 1.228 billion yuan, and 1.455 billion yuan, with a compound annual growth rate (CAGR) of 21.7% [4] - Net profit for the same period is expected to be 202 million yuan, 341 million yuan, and 390 million yuan, with net profit margins of 20.5%, 27.8%, and 26.8% respectively [4] Group 2: Haiwei Electronics - Haiwei Electronics began its IPO process, with subscription open until November 25, and plans to list on the Hong Kong Stock Exchange under the stock code "9609" on November 28, 2025 [6] - The company plans to issue 30,831,400 H-shares, with 3,083,200 shares available for public offering in Hong Kong and 27,748,200 shares for international offering, having secured cornerstone investment exceeding 218 million HKD [6] - Haiwei Electronics is the second-largest manufacturer of capacitor films in China, holding a market share of 10.9% based on revenue from capacitor base films in 2024 [6][7] - The capacitor base film market in China is projected to grow at a CAGR of 19.7%, increasing from 46,200 tons in 2019 to 113,400 tons in 2024, with further growth expected to reach 224,100 tons by 2029 [7] - Haiwei Electronics is the only major manufacturer in China with the capability to design and develop its own capacitor base film production lines, offering a range of film thicknesses from 2.7 to 13.8 microns [7][8]
Canva’s Obrecht says firm eyeing IPO in 'next couple of years'
The Economic Times· 2025-11-22 14:26
Core Insights - Canva was last valued at approximately $42 billion during a share sale [1] - The cofounders of Canva, Obrecht, Melanie Perkins, and Cameron Adams, have appointed Kelly Steckelberg, the former CFO of Zoom Video Communications Inc., as a top financial executive [1] Company Developments - Canva's valuation indicates strong market confidence and growth potential [1] - The hiring of Kelly Steckelberg suggests a strategic move to enhance financial leadership and operational efficiency within the company [1]
U.S. IPO Weekly Recap: 2 IPOs Come To Market, Pipeline Grows Ahead Of Thanksgiving Holiday Week
Seeking Alpha· 2025-11-22 05:20
Group 1 - Two IPOs and one SPAC debuted this week, indicating a continued interest in public offerings [2] - Four IPOs and seven SPACs submitted initial filings, suggesting a robust pipeline for future market activity [2] - Central Bancompany (CBC), based in Missouri, priced its Nasdaq uplisting at the low end of the range to raise $373 million [2]
IPO Stock Of The Week: Insurance Leader Hamilton Rallies To Record Highs Amid Market Volatility
Investors· 2025-11-21 20:06
Core Insights - Hamilton Insurance has experienced a significant rally, reaching record highs amid stock market volatility, positioning itself as a leader in the insurance sector [1][4]. Company Overview - Hamilton Insurance, based in Bermuda, specializes in property and casualty reinsurance, as well as specialty and medical insurance, including coverage for high-risk events such as cyberattacks, kidnappings, and space missions [1]. Stock Performance - Hamilton Insurance's stock has been highlighted as the "IPO Stock of the Week," indicating strong market interest and performance [1][4]. - The stock has regained a key level, placing it in a new buy zone, which reflects renewed investor confidence [2][4]. - The company has shown market leadership with a jump to an 83 Relative Strength (RS) rating, indicating strong technical performance compared to peers [4].
神速!元创股份IPO由注册到生效历时8天,国泰海通保荐
Sou Hu Cai Jing· 2025-11-21 14:39
Core Viewpoint - Yuan Chuang Technology Co., Ltd. has successfully registered its IPO on the Shenzhen Main Board, taking only 8 days from submission to approval, with Guotai Junan Securities as the sponsor [1] Company Overview - Yuan Chuang Technology specializes in the research, production, and sales of rubber track products, including agricultural machinery rubber tracks, engineering machinery rubber tracks, and rubber track plates [3] - The company's products are used in various tracked agricultural and engineering machinery, such as combine harvesters, excavators, loaders, and pavers, serving applications in agriculture and construction [3] Financial Performance - Revenue for the years 2022 to 2024 and the first half of 2025 is projected to be CNY 1.261 billion, CNY 1.141 billion, CNY 1.349 billion, and CNY 652 million respectively [3] - Net profit attributable to the parent company for the same periods is expected to be CNY 139 million, CNY 178 million, CNY 155 million, and CNY 74.155 million [3] Financial Metrics - As of June 30, 2025, total assets are projected to be CNY 2.040 billion, with equity attributable to shareholders at CNY 1.312 billion [4] - The company's debt-to-asset ratio is expected to be 35.68% in 2025, down from 38.09% in 2024 and 33.31% in 2023 [4] - The basic earnings per share for 2025 is projected at CNY 1.26, compared to CNY 2.63 in 2024 and CNY 3.02 in 2023 [4] IPO Fundraising - The IPO aims to raise CNY 485 million for projects including production base construction, technology center development, and working capital supplementation [4]
五粮液:持续壮大“饮的人群”
Xin Lang Cai Jing· 2025-11-21 12:09
Core Viewpoint - Wuliangye (000858) is actively responding to investor concerns regarding the impact of macroeconomic factors on the liquor industry, emphasizing its commitment to innovation and market-centric strategies to enhance value creation [1] Group 1: Industry Concerns - The liquor consumption in China is closely linked to the real estate sector, with historical trends showing that affluent consumers significantly contributed to sales [1] - Macroeconomic challenges such as declining new population numbers, reduced vaccine procurement prices, intense domestic competition, and serious population aging are identified as long-term negative factors for the industry [1] Group 2: Company Strategy - The company plans to proactively innovate and adapt by focusing on customer and market needs, aiming to expand the consumer base, improve purchasing locations, and enrich usage scenarios [1] - Wuliangye's management highlighted their ongoing efforts to strengthen their market position and enhance value creation actions [1] Group 3: Historical Context - The company was listed in 1998, and the costs associated with the legal services during the IPO phase were determined based on regulations at that time [1]
林平发展IPO:业绩不稳、产能闲置、合规瑕疵
Sou Hu Cai Jing· 2025-11-21 09:51
Core Viewpoint - Linping Development's IPO process faces scrutiny due to declining revenue, pricing pressures, and operational risks, raising concerns about its future performance and compliance with regulatory standards [1][8]. Financial Performance - The company's revenue has shown a downward trend, with figures of 28.79 billion yuan in 2022, 28.00 billion yuan in 2023, and projected 24.85 billion yuan in 2024, indicating a year-on-year decline of 2.75% in 2023 and 11.24% in 2024 [2][4]. - Net profit for the same periods was 1.54 billion yuan, 2.12 billion yuan, and 1.53 billion yuan, with a projected 914.19 million yuan for the first half of 2025 [2][3]. Business Operations - The core business of corrugated paper and boxboard sales accounted for over 99% of total revenue, with boxboard consistently representing around 70% of sales [2]. - The average utilization rates for corrugated paper and boxboard production were approximately 80% and 90%, respectively, indicating that current production capacities are not fully utilized [6]. Market Conditions - The cancellation of import tariffs on finished paper in 2023 led to increased competition and a subsequent decline in product prices, impacting revenue negatively [4]. - The company anticipates that demand from sectors such as consumer goods, e-commerce, logistics, and express delivery will support market growth despite current challenges [4]. Capital Expenditure and Risks - The company plans to raise 1.2 billion yuan through its IPO to fund new production lines, which could potentially lead to overcapacity given the current underutilization of existing facilities [6][8]. - Concerns have been raised regarding the company's significantly lower expense ratios compared to industry peers, suggesting possible manipulation of profit figures [6][8]. Compliance and Safety Issues - The company has reported three fatal accidents involving employees during the reporting period, raising questions about its safety management practices [7]. - There have been instances of non-compliance regarding social insurance and housing fund contributions for employees, which could lead to regulatory penalties [7]. Conclusion - Linping Development's IPO is under significant scrutiny due to its declining financial performance, operational challenges, and compliance issues, which must be addressed to gain market acceptance and regulatory approval [8].
兢强科技IPO:“闪电合作”供应商疑点重重 境外销售真实性待考
Xin Lang Zheng Quan· 2025-11-21 05:56
Core Viewpoint - The company, Jingqiang Technology, is preparing for a second IPO attempt after previously withdrawing its application due to significant financial concerns, including volatile profits and negative cash flow [1][2][3] Financial Performance - In 2021, the company's net profit was 91 million, but it plummeted by 54.8% to 52 million in 2022, with non-recurring net profit dropping from 79 million to 36 million [1] - The company has reported negative cash flow from operating activities for seven consecutive years, with figures ranging from -39.96 million in 2018 to -163 million in 2024 [1] Market Concerns - The company has a significantly higher gross margin compared to industry peers, yet its R&D personnel accounted for less than 10% as of June 30, 2021, raising questions about its innovation capabilities [1] - The authenticity of overseas sales is under scrutiny, with 2024 overseas revenue reported at 235 million, a year-on-year increase of 80.5%, but concerns exist regarding the nature of its major clients being traders [2] Supplier Issues - The company's largest supplier, Xiamen Guomao, has shifted away from a long-term supply model, causing its procurement share to drop from 47% to approximately 13% [2] - A new supplier, Shanghai Jituo, has been introduced, with a procurement amount of 528 million in 2024, raising questions about the stability and reliability of the supply chain [2] Corporate Actions - Prior to its IPO application, the company distributed a substantial dividend of 64.67 million, while simultaneously seeking to raise 100 million for liquidity, leading to skepticism about its motives for going public [2] - The company faces increasing scrutiny in a competitive environment, and its ability to address financial concerns and restructure its profit model will be critical for its second IPO attempt [3]
Nasdaq CEO on 'Making IPOs Great Again' and Singapore Exchange Tie-Up
Bloomberg Television· 2025-11-21 02:09
We have a great relationship with the Singapore Exchange. We've been a two decade partner on the technology side and and we have really worked very hard to help them advance their markets. We've we've had different dual listing programs with them.But this one's special and this one is different. The most important difference is if you look at it from the point of view of the issuer itself, these great growth companies that are here in Asia, they want to be able to be able to tap the domestic markets here an ...
X @Bloomberg
Bloomberg· 2025-11-20 20:01
Today in Bloomberg Deals: The US IPO backlog, Abbott buys Exact Sciences and CapVest upstages private equity titans. https://t.co/cuzyVCZvIZ ...